E. Ipatova

Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies

M. Kirpichnikov, A. Moysenovich, K. Shaitan, 2021, Emerging microbes & infections.

Safety and immunogenicity of inactivated whole virion vaccine CoviVac against COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase I/II clinical trial

G. Ignatyev, Y. Ulitina, L. Kozlovskaya, 2022, medRxiv.

Steam explosion treatments of technical hydrolysis lignin

A. Vasilyev, S. Krutov, E. Ipatova, 2017 .

Safety and Immunogenicity of Inactivated Whole Virion COVID-19 Vaccine CoviVac in Clinical Trials in 18–60 and 60+ Age Cohorts

G. Ignatyev, L. Kozlovskaya, V. Akimkin, 2023, Viruses.